Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MTOR Inhibitors”

611 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 611 results

Testing effectiveness (Phase 2)Study completedNCT00281957
What this trial is testing

Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 109
Testing effectiveness (Phase 2)Ended earlyNCT00727207
What this trial is testing

Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy

Who this might be right for
Lymphoma
Technical University of Munich 35
Testing effectiveness (Phase 2)Looking for participantsNCT07191353
What this trial is testing

Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women

Who this might be right for
HealthyOsteopeniaOsteoporosis Risk
Odense University Hospital 148
Early research (Phase 1)Study completedNCT01031901
What this trial is testing

Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)

Who this might be right for
Tuberous SclerosisNeurofibromatosesAngiofibroma+1 more
The University of Texas Health Science Center, Houston 52
Early research (Phase 1)Active Not RecruitingNCT01187199
What this trial is testing

Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer

Who this might be right for
Advanced Cancer
M.D. Anderson Cancer Center 278
Post-approval studies (Phase 4)Study completedNCT02328963
What this trial is testing

Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A

Who this might be right for
Transplantation InfectionCytomegalovirus Infection
University Hospital, Bordeaux 186
Testing effectiveness (Phase 2)Study completedNCT00560963
What this trial is testing

Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine

Who this might be right for
Advanced or Metastatic Pancreatic Adenocarcinoma
Novartis Pharmaceuticals 21
Not applicableStudy completedNCT02328781
What this trial is testing

Prospective Evaluation of Safety and Efficacy Vertebral Drug-eluting Stent System

Who this might be right for
Vertebrobasilar Insufficiency
Zhongrong Miao 101
Testing effectiveness (Phase 2)Study completedNCT00109967
What this trial is testing

CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent Mantle Cell Lymphoma
National Cancer Institute (NCI) 71
Testing effectiveness (Phase 2)Study completedNCT00975819
What this trial is testing

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies

Who this might be right for
Kaposiform HemangioendotheliomasTufted AngiomaCapillary Venous Lymphatic Malformation+6 more
Denise Martin Adams 61
Large-scale testing (Phase 3)UnknownNCT04987463
What this trial is testing

Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants

Who this might be right for
Tuberous Sclerosis Complex
Katarzyna Kotulska 60
Testing effectiveness (Phase 2)Study completedNCT00800917
What this trial is testing

Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Rigshospitalet, Denmark 12
Testing effectiveness (Phase 2)Study completedNCT03522298
What this trial is testing

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

Who this might be right for
Glioblastoma, Adult
Kazia Therapeutics Limited 30
Early research (Phase 1)Study completedNCT01122199
What this trial is testing

Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors

Who this might be right for
Neoplasm Metastases
Shadia Jalal 27
Testing effectiveness (Phase 2)Study completedNCT01206036
What this trial is testing

CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS)

Who this might be right for
Prostatic Neoplasms
Central European Society for Anticancer Drug Research 19
Early research (Phase 1)Study completedNCT00060645
What this trial is testing

Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)

Who this might be right for
TumorsLymphomaMultiple Myeloma
Merck Sharp & Dohme LLC 33
Testing effectiveness (Phase 2)Study completedNCT01510119
What this trial is testing

Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Abramson Cancer Center at Penn Medicine 40
Testing effectiveness (Phase 2)Study completedNCT04488601
What this trial is testing

Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study

Who this might be right for
Aging
AgelessRx 129
Early research (Phase 1)Active Not RecruitingNCT01375829
What this trial is testing

Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Adult Solid Neoplasm
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Study completedNCT00087074
What this trial is testing

CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal TumorRecurrent Adult Soft Tissue SarcomaStage I Adult Soft Tissue Sarcoma+3 more
National Cancer Institute (NCI) 55
Load More Results